Levocetirizina Krka

Levocetirizine, the active ingredient in Levocetirizina Krka, is a second‑generation antihistamine presented as a tablet for oral use. It treats allergic rhinitis and chronic idiopathic urticaria in adults and adolescents by competitively blocking peripheral H1 receptors, thereby reducing sneezing, nasal itching, watery discharge, and skin wheal‑and‑flare reactions. GNH USA supplies Levocetirizina Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levocetirizine, a second‑generation antihistamine, acts on histamine‑mediated allergic pathways to relieve symptoms.

Allergic rhinitis: alleviates nasal congestion, sneezing, itching and rhinorrhea. Chronic idiopathic urticaria: reduces wheal formation, itching and flare reactions. Allergic conjunctivitis: diminishes eye itching, redness and tearing.

Levocetirizine is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Drowsiness or mild sedation - Headache - Dry mouth - Fatigue - Nausea - Abdominal discomfort

Serious or Rare Side Effects: - Angioedema or swelling of the face, lips or tongue - Severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis - Anaphylactic reactions - Hepatic enzyme elevations - Cardiac arrhythmias in susceptible individuals

Levocetirizine should be used with appropriate clinical judgment. - Assess renal function: adjust dosage in patients with severe renal impairment. - Avoid in individuals with known hypersensitivity to levocetirizine or other piperazine antihistamines. - Use caution during pregnancy: consult a healthcare professional before initiating therapy. - Advise patients about possible drowsiness and to avoid operating machinery until they know how the drug affects them. - Store at room temperature: keep in the original container, protect from moisture and light.

Levocetirizine may interact with several concomitant medicines.

Major Interactions (Avoid): - Ketoconazole: can increase levocetirizine plasma concentrations. - Ritonavir: may raise levocetirizine levels leading to enhanced sedation. - Erythromycin: potential to elevate systemic exposure.

Moderate Interactions (Monitor Closely): - Alcohol: additive central nervous system depressant effect. - Other sedating antihistamines or CNS depressants: may increase drowsiness. - Theophylline: possible reduction in theophylline clearance, requiring monitoring.